CASI
CASI Pharmaceuticals, Inc.
No data for this timeframe.
Vol
Recent Activity
May 14, 2026
earnings_calendar
CASI Q1 2026 Earnings Scheduled — 2026-05-14
Price Targets
Historical data — last covering-analyst action Sep 2025. No current recommendation available.
$4.00 (Sep 2025)
Current $0.2075
Low $4.00
Median $4.00
High $4.00
1 analysts
$4.00
$4.00
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 3, 2025 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| May 19, 2025 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Apr 9, 2025 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| May 15, 2024 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Nov 15, 2023 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Next FY | $-1.41 ▲ +2.8% | $-1.41 — $-1.41 | 45% YoY | 1 |
| Current Q | $-0.36 ▲ +2.7% | $-0.36 — $-0.36 | 1 | |
| Next Q | $-0.36 ▲ +2.7% | $-0.36 — $-0.36 | 48% YoY | 1 |
| Current FY | $-2.58 ▼ -11.7% | $-2.58 — $-2.58 | -1% YoY | 1 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Sep 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Sep 2025. No current recommendation available.
$4.00 mean target (Sep 2025)
$4.00 Low
$4.00 High
| Metric | Value |
|---|---|
| Current Price | $0.2075 |
| Target Low | $4.00 |
| Target Mean | $4.00 |
| Target Median | $4.00 |
| Target High | $4.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next FY 2026-12-31 |
$-1.41 | $-1.41 | $-1.41 | 45.3% | +2.8% | 1↑ 0↓ | $0.0B | -100.0% | 1 |
| Current Q 2025-12-31 |
$-0.36 | $-0.36 | $-0.36 | — | +2.7% | 1↑ 0↓ | $0.0B | — | 1 |
| Next Q 2026-03-31 |
$-0.36 | $-0.36 | $-0.36 | 47.8% | +2.7% | — | $0.0B | -100.0% | 1 |
| Current FY 2025-12-31 |
$-2.58 | $-2.58 | $-2.58 | -0.8% | -11.7% | 0↑ 1↓ | $0.0B | — | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.360 | |
| 7d ago | $-0.370 | +0.010 |
| 30d ago | $-0.370 | +0.010 |
| 60d ago | $-0.370 | +0.010 |
| 90d ago | $-0.370 | +0.010 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Sep 3, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 19, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Apr 9, 2025 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Nov 15, 2023 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Aug 14, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 22, 2023 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jun 1, 2023 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2023 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Apr 1, 2023 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Mar 1, 2023 | 3 | 4 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 14, 2026
earnings_calendar
CASI Q1 2026 Earnings Scheduled — 2026-05-14
Apr 29, 2026
earnings_calendar
CASI Q4 2025 Earnings Before Market Open — 2026-04-29
Mar 30, 2026
earnings_calendar
CASI Q4 2025 Earnings Before Market Open — 2026-03-30